Glucotrack (GCTK) Research & Development (2010 - 2025)
Glucotrack (GCTK) recorded quarterly Research & Development of $1.6 million in Q4 2025, down 48.59% on a QoQ basis from $3.2 million in Q3 2025, and down 4.24% year-over-year from $1.7 million in Q4 2024.
Glucotrack (GCTK) Research & Development (2010 - 2025) Analysis & Trends
Glucotrack has disclosed Research & Development across 15 years of filings, most recently posting $1.6 million for Q4 2025.
- Quarterly Research & Development fell 4.24% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.8 million (up 3.31% YoY) and the FY2025 annual result came in at $9.8 million, up 3.31% from the prior year.
- Research & Development retreated to $1.6 million in Q4 2025, from $3.2 million in the prior quarter.
- Over five years, Research & Development peaked at $3.6 million in Q2 2024 and troughed at $309000.0 in Q1 2021.
- A 5-year average of $1.4 million and a median of $1.2 million in 2021 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2021 — Research & Development retreated 25.18% — and 2024, when it soared 472.41%.
- Tracing GCTK's Research & Development over 5 years: stood at $733000.0 in 2021, then slipped by 17.6% to $604000.0 in 2022, then surged by 188.41% to $1.7 million in 2023, then fell by 2.47% to $1.7 million in 2024, then fell by 4.24% to $1.6 million in 2025.
- Business Quant data shows GCTK's Research & Development at $1.6 million in Q4 2025, $3.2 million in Q3 2025, and $3.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 94.27 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 15.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 189.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 98.66 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 139.00 Mn |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 1.87 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 3.59 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 1.74 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 627,000.00 |
| Mar 31, 2023 | 642,000.00 |
| Dec 31, 2022 | 604,000.00 |
| Sep 30, 2022 | 434,000.00 |
| Jun 30, 2022 | 469,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Dec 31, 2021 | 733,000.00 |
| Sep 30, 2021 | 447,000.00 |
| Jun 30, 2021 | 321,000.00 |
| Mar 31, 2021 | 309,000.00 |